Valuation: Illumina, Inc.

Capitalization 19.71B 16.94B 15.87B 14.79B 27.32B 1,773B 29.71B 186B 71.66B 838B 73.96B 72.38B 3,063B P/E ratio 2025 *
29.8x
P/E ratio 2026 * 29x
Enterprise value 20.46B 17.58B 16.47B 15.35B 28.36B 1,841B 30.85B 193B 74.39B 869B 76.78B 75.14B 3,179B EV / Sales 2025 *
4.77x
EV / Sales 2026 * 4.45x
Free-Float
79.72%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.73%
1 week-1.89%
Current month-1.89%
1 month+5.79%
3 months+30.35%
6 months+56.01%
Current year-3.49%
More quotes
1 week 124.27
Extreme 124.27
129.72
1 month 117.1
Extreme 117.1
132.15
Current year 68.7
Extreme 68.7
153.06
1 year 68.7
Extreme 68.7
153.06
3 years 68.7
Extreme 68.7
238.55
5 years 68.7
Extreme 68.7
555.77
10 years 68.7
Extreme 68.7
555.77
More quotes
Manager TitleAgeSince
Chief Executive Officer 50 2023-09-24
Director of Finance/CFO 49 2024-04-14
Chief Tech/Sci/R&D Officer - 2023-08-08
Director TitleAgeSince
Director/Board Member 70 2012-11-28
Director/Board Member 68 2016-01-27
Director/Board Member 64 2016-07-27
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.73%-1.89%-8.60%-38.15% 19.71B
-0.43%-3.06%+8.20%+2.62% 215B
+1.18%+0.32%+4.53%+114.71% 204B
-0.39%-0.23%-1.68%-15.65% 160B
-0.20%-4.00%+8.27%+113.72% 145B
+0.33%+2.49%-16.63%-11.71% 56.48B
+0.48%-0.55%+20.49%+18.75% 50.02B
-1.91%-5.22%+3.49%-5.36% 41.18B
+3.56%+6.84%+5.19% - 38.93B
+2.00%+0.28%+6.27%+15.47% 37.39B
Average +0.45%-0.59%+2.95%+21.60% 96.72B
Weighted average by Cap. +0.49%-1.16%+4.25%+40.70%
See all sector performances

Financials

2025 *2026 *
Net sales 4.29B 3.68B 3.45B 3.22B 5.94B 386B 6.46B 40.37B 15.59B 182B 16.09B 15.74B 666B 4.38B 3.77B 3.53B 3.29B 6.07B 394B 6.6B 41.25B 15.93B 186B 16.44B 16.09B 681B
Net income 663M 570M 534M 497M 919M 59.63B 999M 6.24B 2.41B 28.16B 2.49B 2.43B 103B 671M 576M 540M 503M 930M 60.35B 1.01B 6.32B 2.44B 28.5B 2.52B 2.46B 104B
Net Debt 751M 645M 605M 564M 1.04B 67.58B 1.13B 7.07B 2.73B 31.92B 2.82B 2.76B 117B -209M -180M -169M -157M -290M -18.84B -316M -1.97B -761M -8.9B -786M -769M -32.53B
More financial data * Estimated data
Logo Illumina, Inc.
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.
Employees
9,000
More about the company
Date Price Change Volume
25-12-05 128.96 $ +0.73% 823,388
25-12-04 128.03 $ +0.06% 948,529
25-12-03 127.95 $ +0.31% 831,631
25-12-02 127.55 $ -0.91% 1,091,291
25-12-01 128.72 $ -2.08% 1,932,723

Delayed Quote Nasdaq, December 05, 2025 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
128.96USD
Average target price
121.39USD
Spread / Average Target
-5.87%
Consensus

Quarterly revenue - Rate of surprise